Oncobiologics Inc (NASDAQ:ONS)

0.84
Delayed Data
As of Aug 14
 -0.0099 / -1.16%
Today’s Change
0.78
Today|||52-Week Range
2.30
-35.38%
Year-to-Date
No recent news for Oncobiologics Inc.

Today’s Trading

Previous close0.85
Today’s open0.81
Day’s range0.81 - 0.85
Volume3,102
Average volume (3 months)51,441
Market cap$27.5M
Data as of 3:49pm ET, 08/14/2018

Growth & Valuation

Earnings growth (last year)+50.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+27.92%
P/E ratioNM
Price/Sales8.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DRIODarioHealth Corp+0.04+3.48%
PTIEPain Therapeutics In...-0.11-9.10%
BNTCBenitec Biopharma Lt...-0.05-1.68%
----
Data as of 3:59pm ET, 08/14/2018

Financials

Next reporting dateAugust 29, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$3.8M
Annual profit (last year)-$40.0M
Net profit margin-1,050.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Lawrence A. Kenyon
Chief Medical Officer
Kenneth M. Bahrt
Corporate headquarters
Cranbury, New Jersey

Forecasts